Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$7.45−0.34 (-4.36%)
Close on Nov 20, 2026Market cap $1.36BP/E –Yield –
Teladoc Health gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Teladoc Health's gross profit for the twelve months ending Sep 30, 2026 was $1.69B, down 4.1% year over year. For fiscal 2025 it was $1.76B, down 3.3% from the year before. Over ten years it grew 41.1% a year on average. The highest annual figure on record is $1.84B in fiscal 2023.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | -3.3% |
| FY2024 | Dec 31, 2024 | $1.82B | -1.3% |
| FY2023 | Dec 31, 2023 | $1.84B | +10.8% |
| FY2022 | Dec 31, 2022 | $1.66B | +20.3% |
| FY2021 | Dec 31, 2021 | $1.38B | +96.6% |
| FY2020 | Dec 31, 2020 | $703.13M | +90.6% |
| FY2019 | Dec 31, 2019 | $368.84M | +27.6% |
| FY2018 | Dec 31, 2018 | $289.17M | +68.5% |
| FY2017 | Dec 31, 2017 | $171.66M | +88.2% |
| FY2016 | Dec 31, 2016 | $91.19M | +61.8% |
| FY2015 | Dec 31, 2015 | $56.34M | +67.7% |
| FY2014 | Dec 31, 2014 | $33.60M | +113.7% |
| FY2013 | Dec 31, 2013 | $15.72M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $414.84M | -5.6% |
| Q2 FY2026 | Jun 30, 2026 | $416.09M | -5.7% |
| Q1 FY2026 | Mar 31, 2026 | $416.32M | -3.8% |
| Q4 FY2025 | Dec 31, 2025 | $445.22M | -1.4% |
| Q3 FY2025 | Sep 30, 2025 | $439.26M | -4.7% |
| Q2 FY2025 | Jun 30, 2025 | $441.36M | -2.9% |
| Q1 FY2025 | Mar 31, 2025 | $432.54M | -4.2% |
| Q4 FY2024 | Dec 31, 2024 | $451.56M | -3.3% |
| Q3 FY2024 | Sep 30, 2024 | $460.76M | -2.8% |
| Q2 FY2024 | Jun 30, 2024 | $454.39M | -1.6% |
| Q1 FY2024 | Mar 31, 2024 | $451.59M | +2.8% |
| Q4 FY2023 | Dec 31, 2023 | $467.10M | +4.1% |
| Q3 FY2023 | Sep 30, 2023 | $474.28M | +11.4% |
| Q2 FY2023 | Jun 30, 2023 | $461.87M | +12.7% |
| Q1 FY2023 | Mar 31, 2023 | $439.14M | +16.1% |
| Q4 FY2022 | Dec 31, 2022 | $448.84M | +18.3% |
| Q3 FY2022 | Sep 30, 2022 | $425.78M | +20.7% |
| Q2 FY2022 | Jun 30, 2022 | $409.91M | +19.6% |
| Q1 FY2022 | Mar 31, 2022 | $378.33M | +22.9% |
| Q4 FY2021 | Dec 31, 2021 | $379.25M | +45.7% |
| Q3 FY2021 | Sep 30, 2021 | $352.62M | +91.5% |
| Q2 FY2021 | Jun 30, 2021 | $342.87M | +128.2% |
| Q1 FY2021 | Mar 31, 2021 | $307.72M | +183.8% |
| Q4 FY2020 | Dec 31, 2020 | $260.38M | +157.5% |
| Q3 FY2020 | Sep 30, 2020 | $184.09M | +93.4% |
| Q2 FY2020 | Jun 30, 2020 | $150.25M | +69.5% |
| Q1 FY2020 | Mar 31, 2020 | $108.42M | +29.2% |
| Q4 FY2019 | Dec 31, 2019 | $101.13M | +22.3% |
| Q3 FY2019 | Sep 30, 2019 | $95.17M | +23.9% |
| Q2 FY2019 | Jun 30, 2019 | $88.64M | +32.5% |
| Q1 FY2019 | Mar 31, 2019 | $83.90M | +33.6% |
| Q4 FY2018 | Dec 31, 2018 | $82.71M | +52.0% |
| Q3 FY2018 | Sep 30, 2018 | $76.80M | +47.9% |
| Q2 FY2018 | Jun 30, 2018 | $66.88M | +93.5% |
| Q1 FY2018 | Mar 31, 2018 | $62.79M | +104.1% |
| Q4 FY2017 | Dec 31, 2017 | $54.42M | +98.8% |
| Q3 FY2017 | Sep 30, 2017 | $51.91M | – |
| Q2 FY2017 | Jun 30, 2017 | $34.57M | – |
| Q1 FY2017 | Mar 31, 2017 | $30.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.38M | – |
See a number that looks wrong?